Open study of the clinical effect of suprofen drops in children

Insights

Suprofen (alpha-methyl-4-(2-thienyl-carbonyl)phenylacetic acid) effectively reduced fever in children. This antipyretic medication demonstrated good tolerability and acceptance in an open study.

Area of Science:

  • Pediatrics
  • Pharmacology
  • Clinical Medicine

Background:

  • Fever is a common symptom in children requiring effective and safe management.
  • Alpha-methyl-4-(2-thienyl-carbonyl)phenylacetic acid (suprofen) is a non-steroidal anti-inflammatory drug (NSAID) with potential antipyretic properties.

Purpose of the Study:

  • To evaluate the antipyretic effect of suprofen drops in children with fever.
  • To assess the tolerability and acceptance of suprofen drops in a pediatric population.

Main Methods:

  • An open-label study was conducted with 111 children experiencing fever of various etiologies.
  • Suprofen drops were administered based on body weight and age, up to four times daily for a maximum of four days.
  • Rectal temperature, pulse rate, and respiratory rate were monitored at multiple time points post-administration.

Main Results:

  • An 89% good appreciation of the antipyretic effect was reported.
  • Statistically significant reductions in body temperature were observed at all measured time points after the first dose.
  • Adverse drug experiences (vomiting, loose stools) were infrequent (5 cases), with good tolerability (96%) and acceptance (94%) noted.

Conclusions:

  • Suprofen drops demonstrated significant efficacy as an antipyretic agent in children.
  • The medication was well-tolerated and accepted by the pediatric patients in this study.
  • Suprofen represents a potentially valuable option for fever management in children.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...